Q3 2018 Holdings
Filed 2018-11-13 | 21 holdings | $56.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arbutus Biopharma Corporation(ABUS) | COM | 03879J100 | $25.3M | 2,676,825 | 45.0% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $17.4M | 245,424 | 31.0% |
| Aclaris Therapeutics, Inc.(ACRS) | COM | 00461U105 | $7.7M | 529,551 | 13.7% |
| Arcus Biosciences, Inc.(RCUS) | COM | 03969F109 | $4.1M | 295,000 | 7.3% |
| Crinetics Pharmaceuticals, Inc.(CRNX) | COM | 22663K107 | $1.4M | 49,600 | 2.5% |
| Insmed Incorporated(INSM) | COM | 457669307 | $36.4K | 1,800,587 | 0.1% |
| Myokardia, Inc. | COM | 62857M105 | $33.3K | 511,244 | 0.1% |
| Biohaven Pharmaceutical Holding Company Ltd.(BHVN) | COM | G11196105 | $32.0K | 851,200 | 0.1% |
| Immunomedics, Inc.(IMMU) | COM | 452907108 | $25.7K | 1,231,543 | 0.0% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $22.4K | 2,023,369 | 0.0% |
| Rhythm Pharmaceuticals, Inc.(RYTM) | COM | 76243J105 | $20.3K | 696,903 | 0.0% |
| Replimune Group, Inc.(REPL) | COM | 76029N106 | $19.8K | 1,229,656 | 0.0% |
| OptiNose, Inc. | COM | 68404V100 | $18.1K | 1,458,545 | 0.0% |
| Alder BioPharmaceuticals, Inc.(ALDR1EUR) | COM | 014339105 | $16.7K | 1,000,919 | 0.0% |
| Omeros Corp.(OMER) | COM | 682143102 | $8.7K | 356,000 | 0.0% |
| Eidos Therapeutics, Inc.(EIDXGBP) | COM | 28249H104 | $5.2K | 525,000 | 0.0% |
| Xenon Pharmaceuticals, Inc.(XENE) | COM | 98420N105 | $5.1K | 385,714 | 0.0% |
| Gritstone Oncology, Inc.(2JQ) | COM | 39868T105 | $2.5K | 175,000 | 0.0% |
| Kiniksa Pharmaceuticals, Ltd. | Class A Common | G5269C101 | $2.4K | 94,477 | 0.0% |
| uniQure N.V.(QURE) | SHS | N90064101 | $388 | 10,650 | 0.0% |
| Verona Pharma Plc(VRNA) | SPONSORED ADS | 925050106 | $104 | 8,302 | 0.0% |